Oppenheimer Asset Management Inc. Jazz Pharmaceuticals PLC Transaction History
Oppenheimer Asset Management Inc.
- $8.4 Billion
- Q2 2025
A detailed history of Oppenheimer Asset Management Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 10,382 shares of JAZZ stock, worth $1.42 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,382
Previous 10,191
1.87%
Holding current value
$1.42 Million
Previous $1.27 Million
12.96%
% of portfolio
0.01%
Previous 0.02%
Shares
29 transactions
Others Institutions Holding JAZZ
# of Institutions
565Shares Held
62.3MCall Options Held
563KPut Options Held
79.8K-
Black Rock Inc. New York, NY6.15MShares$838 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.09MShares$830 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.55MShares$348 Million0.65% of portfolio
-
Capital World Investors Los Angeles, CA2.54MShares$347 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.54MShares$346 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.54B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...